Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Internalization and degradation of heparin binding growth factor-I by endothelial cells

Identifieur interne : 003248 ( Main/Exploration ); précédent : 003247; suivant : 003249

Internalization and degradation of heparin binding growth factor-I by endothelial cells

Auteurs : Robert Friesel [États-Unis] ; Thomas Maciag [États-Unis]

Source :

RBID : ISTEX:E597DD559AB8C908EC1519645DA22922BA1F0D9F

Descripteurs français

English descriptors

Abstract

Summary: The fate of 125I-labeled heparin binding growth factor I (125I-HBGF-I) after binding to its cell surface receptor has been studied using murine lung capillary endothelial cells (LEII). Binding of 125I-HBGF-I to its receptor at 4°C shows pH dependence with optimal binding at pH 6.5–7.5. The majority (∼80%) of 125I-HBGF-I bound to cells at 4°C can be removed by washing with low pH medium, but rapidly becomes acid resistant upon shifting cells to 37°C, with 50% of the 125I-HBGF-I becoming acid resistant after 20 minutes. Electrophoretic analysis of internalized 125I-HBGF-I shows that degradation begins approximately 2 hours after internalization with the appearance of two major labeled fragments of Mr 15,000 and Mr 10,000. Degradation of internalized 125I-HBGF-I is inhibited by the lysosomotropic agent chloroquine. These data suggest that cell-associated 125I-HBGF-I is rapidly internalized and directed to a lysosomal cellular compartment where it is slowly degraded.

Url:
DOI: 10.1016/S0006-291X(88)80459-5


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Internalization and degradation of heparin binding growth factor-I by endothelial cells</title>
<author>
<name sortKey="Friesel, Robert" sort="Friesel, Robert" uniqKey="Friesel R" first="Robert" last="Friesel">Robert Friesel</name>
</author>
<author>
<name sortKey="Maciag, Thomas" sort="Maciag, Thomas" uniqKey="Maciag T" first="Thomas" last="Maciag">Thomas Maciag</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E597DD559AB8C908EC1519645DA22922BA1F0D9F</idno>
<date when="1988" year="1988">1988</date>
<idno type="doi">10.1016/S0006-291X(88)80459-5</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-56VRVM2J-X/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000F61</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F61</idno>
<idno type="wicri:Area/Istex/Curation">000F61</idno>
<idno type="wicri:Area/Istex/Checkpoint">002010</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002010</idno>
<idno type="wicri:doubleKey">0006-291X:1988:Friesel R:internalization:and:degradation</idno>
<idno type="wicri:Area/Main/Merge">003319</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:2451523</idno>
<idno type="wicri:Area/PubMed/Corpus">000575</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000575</idno>
<idno type="wicri:Area/PubMed/Curation">000575</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000575</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000545</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000545</idno>
<idno type="wicri:Area/Ncbi/Merge">000238</idno>
<idno type="wicri:Area/Ncbi/Curation">000238</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000238</idno>
<idno type="wicri:doubleKey">0006-291X:1988:Friesel R:internalization:and:degradation</idno>
<idno type="wicri:Area/Main/Merge">003257</idno>
<idno type="wicri:Area/Main/Curation">003248</idno>
<idno type="wicri:Area/Main/Exploration">003248</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Internalization and degradation of heparin binding growth factor-I by endothelial cells</title>
<author>
<name sortKey="Friesel, Robert" sort="Friesel, Robert" uniqKey="Friesel R" first="Robert" last="Friesel">Robert Friesel</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Molecular Biology Jerome H. Holland Laboratory for the Biomedical Sciences American Red Cross 15601 Crabbs Branch Way Rockville, Maryland 20855</wicri:regionArea>
<wicri:noRegion>Maryland 20855</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Maciag, Thomas" sort="Maciag, Thomas" uniqKey="Maciag T" first="Thomas" last="Maciag">Thomas Maciag</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Molecular Biology Jerome H. Holland Laboratory for the Biomedical Sciences American Red Cross 15601 Crabbs Branch Way Rockville, Maryland 20855</wicri:regionArea>
<wicri:noRegion>Maryland 20855</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Biochemical and Biophysical Research Communications</title>
<title level="j" type="abbrev">YBBRC</title>
<idno type="ISSN">0006-291X</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1988">1988</date>
<biblScope unit="volume">151</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="957">957</biblScope>
<biblScope unit="page" to="964">964</biblScope>
</imprint>
<idno type="ISSN">0006-291X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0006-291X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Capillaries</term>
<term>Chloroquine (pharmacology)</term>
<term>EDTA</term>
<term>EGF</term>
<term>Endothelium, Vascular (drug effects)</term>
<term>Endothelium, Vascular (metabolism)</term>
<term>Fibroblast Growth Factor 1</term>
<term>Growth Substances (metabolism)</term>
<term>HBGF-I</term>
<term>HEPES</term>
<term>Heparin (metabolism)</term>
<term>Hydrogen-Ion Concentration</term>
<term>Kinetics</term>
<term>Mice</term>
<term>Molecular Weight</term>
<term>PMSF</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Chloroquine (pharmacologie)</term>
<term>Cinétique</term>
<term>Concentration en ions d'hydrogène</term>
<term>Endothélium vasculaire ()</term>
<term>Endothélium vasculaire (métabolisme)</term>
<term>Facteur de croissance fibroblastique de type 1</term>
<term>Héparine (métabolisme)</term>
<term>Masse moléculaire</term>
<term>Souris</term>
<term>Substances de croissance (métabolisme)</term>
<term>Vaisseaux capillaires</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Growth Substances</term>
<term>Heparin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Chloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Endothelium, Vascular</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Endothelium, Vascular</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Endothélium vasculaire</term>
<term>Héparine</term>
<term>Substances de croissance</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Chloroquine</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Academic press</term>
<term>Acetic acid</term>
<term>Animals</term>
<term>Binding buffer</term>
<term>Biophysical</term>
<term>Biophysical research communications</term>
<term>Capillaries</term>
<term>Cell lysates</term>
<term>Cell physiol</term>
<term>Cell surface</term>
<term>Cell surface receptors</term>
<term>Cell types</term>
<term>Chloroquine</term>
<term>Cold binding buffer</term>
<term>Confluent monolayers</term>
<term>Electrophoretic analysis</term>
<term>Endothelial</term>
<term>Endothelial cells</term>
<term>Fibroblast Growth Factor 1</term>
<term>Friesel</term>
<term>Growth factor</term>
<term>Growth factors</term>
<term>Heparin</term>
<term>Heparin binding growth factor</term>
<term>Human gliomas</term>
<term>Hydrogen-Ion Concentration</term>
<term>Incubation medium</term>
<term>Kinetics</term>
<term>Leii</term>
<term>Leii ceils</term>
<term>Leii cells</term>
<term>Ligand</term>
<term>Mice</term>
<term>Mitogenic response</term>
<term>Mitogenic signal</term>
<term>Molecular Weight</term>
<term>Receptor</term>
<term>Specific binding</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cinétique</term>
<term>Concentration en ions d'hydrogène</term>
<term>Endothélium vasculaire</term>
<term>Facteur de croissance fibroblastique de type 1</term>
<term>Masse moléculaire</term>
<term>Souris</term>
<term>Vaisseaux capillaires</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Summary: The fate of 125I-labeled heparin binding growth factor I (125I-HBGF-I) after binding to its cell surface receptor has been studied using murine lung capillary endothelial cells (LEII). Binding of 125I-HBGF-I to its receptor at 4°C shows pH dependence with optimal binding at pH 6.5–7.5. The majority (∼80%) of 125I-HBGF-I bound to cells at 4°C can be removed by washing with low pH medium, but rapidly becomes acid resistant upon shifting cells to 37°C, with 50% of the 125I-HBGF-I becoming acid resistant after 20 minutes. Electrophoretic analysis of internalized 125I-HBGF-I shows that degradation begins approximately 2 hours after internalization with the appearance of two major labeled fragments of Mr 15,000 and Mr 10,000. Degradation of internalized 125I-HBGF-I is inhibited by the lysosomotropic agent chloroquine. These data suggest that cell-associated 125I-HBGF-I is rapidly internalized and directed to a lysosomal cellular compartment where it is slowly degraded.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<country name="États-Unis">
<noRegion>
<name sortKey="Friesel, Robert" sort="Friesel, Robert" uniqKey="Friesel R" first="Robert" last="Friesel">Robert Friesel</name>
</noRegion>
<name sortKey="Maciag, Thomas" sort="Maciag, Thomas" uniqKey="Maciag T" first="Thomas" last="Maciag">Thomas Maciag</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003248 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003248 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:E597DD559AB8C908EC1519645DA22922BA1F0D9F
   |texte=   Internalization and degradation of heparin binding growth factor-I by endothelial cells
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021